Hydrochloric Acid

Hydrochloric Acid

SCHEMBL219833

CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC.[Cl-]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.94
DNM1 Q05193 11/20 0.88
KMT2A Q03164 1/20 0.74
HSP90AA1 P07900 2/20 0.71
RAD52 P43351 2/20 0.71
PLA2G1B P04054 1/20 0.71
ATG4B Q9Y4P1 1/20 0.71
SLC22A1 O15245 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6141885 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL24409 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL6572413 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL18139636 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL8157421 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL2980556 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL25287222 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL22206819 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL22436441 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52
Hydrochloric Acid SCHEMBL6891041 1.00 HTT (0.94) HTTDNM1KMT2AHSP90AA1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037651-A Smooth touch offset printing gloss oil composition, application method thereof and printed matter 本溪九星印刷包装有限公司 2026-05-15 CN claimed
US-20260055056-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE WILLIAM M YARBROUGH FOUND (US) 2026-02-26 US claimed
US-12492339-B2 Quantum dot film, quantum dot light-emitting diode and preparation method thereof TCL TECHNOLOGY GROUP CORPORATION (CN) 2025-12-09 US claimed
US-20250325493-A1 COMPOSITIONS AND METHODS FOR MAKING AND USING POLYMER-COATED NANOCAPSULES FOR TARGETED PHARMACEUTICAL AGENT DELIVERY UNIV COLORADO REGENTS (US) 2025-10-23 US claimed
EP-4626408-A2 COMPOSITIONS AND METHODS FOR MAKING AND USING POLYMER-COATED NANOCAPSULES FOR TARGETED PHARMACEUTICAL AGENT DELIVERY Colorado School Of Mines (US) 2025-10-08 EP claimed
CN-120137658-A Ytterbium-doped perovskite quantum dot and preparation method and application thereof 极电光能有限公司 2025-06-13 CN claimed
CN-111718716-B Nanostructure with inorganic ligands for electroluminescent devices 昭荣化学工业株式会社 2025-06-10 CN claimed
US-12310939-B2 Method for treating rheumatoid arthritis THE WILLIAM YARBROUGH FOUNDATION (US) 2025-05-27 US claimed
US-20250161258-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE THE WILLIAM M YARBROUGH FOUND (US) 2025-05-22 US claimed
CN-116750968-B Inorganic ecological stone with good waterproof and anti-fouling properties and preparation process thereof 广州市恒宏生态建材有限公司 2025-04-22 CN claimed
US-6531444-B1 Fragrant burst upon ironing; hydrophobic candelilla wax/silicon copolymer; cationic charge boosters and fabric softeners SALVONA, LLC 2003-03-11 US claimed
US-20020189040-A1 Cleaning towel having a color identifying label and sanitizer release polymer composition COMMUN-I-TEC, LTD. 2002-12-19 US claimed
US-20020132866-A1 Composition for regenerating an ion exchange resin EVEN WILLIAM R (US) 2002-09-19 US claimed
WO-2002038713-A1 A CONTROLLED DELIVERY SYSTEM FOR FABRIC CARE PRODUCTS SALVONA, L.L.C. (US) 2002-05-16 WO claimed
EP-0841898-B1 TOPICAL COMPOSITIONS HAVING IMPROVED SKIN FEEL PROCTER & GAMBLE (US) 2002-01-23 EP claimed
EP-0841899-B1 COMPOSITIONS FOR TOPICAL DELIVERY OF ACTIVE INGREDIENTS PROCTER & GAMBLE (US) 2001-12-19 EP claimed
EP-0777465-B1 THICKENED NONABRASIVE PERSONAL CLEANSING COMPOSITIONS PROCTER & GAMBLE (US) 1999-11-03 EP claimed
EP-0714283-B1 PERSONAL CLEANSING COMPOSITIONS PROCTER & GAMBLE (US) 1999-05-12 EP claimed
EP-0693920-B1 COMPOSITIONS FOR IMPARTING AN ARTIFICIAL TAN AND PROTECTING THE SKIN FROM UV RADIATION PROCTER & GAMBLE (US) 1998-01-28 EP claimed
EP-0037161-B1 CREAMY CLEANSING COMPOSITIONS Kao Corporation (JP) 1983-11-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055056-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE ALK, C9, MSR1 HTT 3016/4885DNM1 4860/4885KMT2A 3841/4885
US-12310939-B2 Method for treating rheumatoid arthritis MIF, TNF, MMP12 HTT 2224/4885DNM1 3267/4885KMT2A 2040/4885
US-20250161258-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE TST, TMSB10, NHERF1 HTT 763/4885DNM1 3740/4885KMT2A 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.